Please enable JavaScript to continue using this application.

Compare $MIRM vs $PTCT | Chartloom

Compare

$MIRM vs $PTCT

Mirum Pharmaceuticals Inc · PTC Therapeutics Inc

MIRM

Mirum Pharmaceuticals Inc

PTCT

PTC Therapeutics Inc

Compare $MIRM vs $PTCT

Comparing Mirum Pharmaceuticals Inc and PTC Therapeutics Inc

MIRMMirum Pharmaceuticals Inc

PTCTPTC Therapeutics Inc

MIRMMirum Pharmaceuticals Inc

Market cap

$5.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.85x

Rev growth (TTM)

44.0%

YTD performance

10.2%

52W performance

18.1%

FCF yield

-5.0%

PTCTPTC Therapeutics Inc

Market cap

$5.37B

P/E (TTM)

—

Forward P/E (NTM)

43.00x

Forward P/S (NTM)

4.18x

Rev growth (TTM)

-36.7%

YTD performance

-15.7%

52W performance

0.3%

FCF yield

-0.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MIRM

PTCT

Detailed metrics comparison

MIRM

Mirum Pharmaceuticals Inc

PTCT

PTC Therapeutics Inc

Market Cap

MIRM$5.24B

PTCT$5.37B

Enterprise Value

MIRM$5.66B

PTCT$7.24B

Price

MIRM$86.01

PTCT$64.70

P/E Ratio

MIRMN/A

PTCTN/A

P/S Ratio

MIRM8.49x

PTCT5.32x

EV/Sales

MIRM9.16x

PTCT7.17x

EV/EBITDA

MIRM2,753.41x

PTCT35.21x

P/B Ratio

MIRM22.21x

PTCT3,530.95x

P/FCF Ratio

MIRMN/A

PTCTN/A

EV/FCF

MIRM-21.48x

PTCT-182.20x

PEG Ratio

MIRMN/A

PTCTN/A

Forward P/E (NTM)

MIRMN/A

PTCT43.00x

Forward P/S (NTM)

MIRM6.85x

PTCT4.18x

Revenue (TTM)

MIRM$618M

PTCT$1.01B

Revenue Growth (YoY)

MIRM44.0%

PTCT-36.7%

Forward Rev Growth

MIRM17.0%

PTCT11.6%

Gross Margin (TTM)

MIRM81.7%

PTCT93.0%

Operating Margin (TTM)

MIRM0.0%

PTCT12.4%

EBITDA Margin (TTM)

MIRM-10.6%

PTCT17.1%

Net Margin (TTM)

MIRM-139.2%

PTCT-3.8%

FCF Margin (TTM)

MIRM-42.7%

PTCT-3.9%

Net Income (TTM)

MIRM$-860M

PTCT$-38M

FCF (TTM)

MIRM$-264M

PTCT$-40M

EPS (TTM)

MIRM-$13.57

PTCT-$0.42

ROE (TTM)

MIRM-28933.0%

PTCT-35191.0%

ROA (TTM)

MIRM-9655.0%

PTCT-132.0%

ROIC (TTM)

MIRM-13639.0%

PTCT-3977.0%

Cash

MIRM$331M

PTCT$1.05B

Debt

MIRM$750M

PTCT$2.92B

Net Cash/Debt

MIRM$-419M

PTCT$-1.87B

Current Ratio (TTM)

MIRM2.86x

PTCT3.39x

Quick Ratio (TTM)

MIRM2.62x

PTCT3.20x

Debt/Equity (TTM)

MIRM1.28x

PTCT848.93x

Debt/Assets (TTM)

MIRM0.0%

PTCT0.0%

Interest Coverage (TTM)

MIRMN/A

PTCTN/A

Net Debt/EBITDA (TTM)

MIRM0.00x

PTCT0.00x

Beta

MIRM0.75

PTCT0.50

52W Performance

MIRM18.1%

PTCT0.3%

YTD Performance

MIRM10.2%

PTCT-15.7%

% from 52W High

MIRM-33.8%

PTCT-28.8%

% from 52W Low

MIRM36.0%

PTCT5.7%

Asset Turnover (TTM)

MIRM0.69x

PTCT0.35x

FCF Yield (TTM)

MIRM-5.0%

PTCT-0.7%

Earnings Yield (TTM)

MIRM-16.4%

PTCT-0.7%

Dividend Yield (TTM)

MIRMN/A

PTCTN/A

Rule of 40

MIRM1.3

PTCT-40.7

EV/GP/RG

MIRM0.45

PTCT0.24

Ticker research

View MIRM research View PTCT research

Metric	MIRM Mirum Pharmaceuticals Inc	PTCT PTC Therapeutics Inc
Market & Valuation
Market Cap	$5.24B	$5.37B
Enterprise Value	$5.66B	$7.24B
Price	$86.01	$64.70
P/E Ratio	N/A	N/A
P/S Ratio	8.49x	5.32x
EV/Sales	9.16x	7.17x
EV/EBITDA	2,753.41x	35.21x
P/B Ratio	22.21x	3,530.95x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.48x	-182.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	43.00x
Forward P/S (NTM)	6.85x	4.18x
Revenue & Growth
Revenue (TTM)	$618M	$1.01B
Revenue Growth (YoY)	44.0%	-36.7%
Forward Rev Growth	17.0%	11.6%
Profitability
Gross Margin (TTM)	81.7%	93.0%
Operating Margin (TTM)	0.0%	12.4%
EBITDA Margin (TTM)	-10.6%	17.1%
Net Margin (TTM)	-139.2%	-3.8%
FCF Margin (TTM)	-42.7%	-3.9%
Net Income (TTM)	$-860M	$-38M
FCF (TTM)	$-264M	$-40M
EPS (TTM)	-$13.57	-$0.42
ROE (TTM)	-28933.0%	-35191.0%
ROA (TTM)	-9655.0%	-132.0%
ROIC (TTM)	-13639.0%	-3977.0%
Financial Health
Cash	$331M	$1.05B
Debt	$750M	$2.92B
Net Cash/Debt	$-419M	$-1.87B
Current Ratio (TTM)	2.86x	3.39x
Quick Ratio (TTM)	2.62x	3.20x
Debt/Equity (TTM)	1.28x	848.93x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	0.50
52W Performance	18.1%	0.3%
YTD Performance	10.2%	-15.7%
% from 52W High	-33.8%	-28.8%
% from 52W Low	36.0%	5.7%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.35x
FCF Yield (TTM)	-5.0%	-0.7%
Earnings Yield (TTM)	-16.4%	-0.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1.3	-40.7
EV/GP/RG	0.45	0.24
Ticker research	View MIRM research	View PTCT research

Valuation

P/S Ratio

PTCT

5.32x

MIRM

8.49x

EV/FCF

PTCT

-182.20x

MIRM

-21.48x

Growth & revenue

Revenue Growth TTM

MIRM

44.0%

PTCT

-36.7%

Forward Revenue Growth

MIRM

17.0%

PTCT

11.6%

Profitability & performance

Gross Margin

PTCT

93.0%

MIRM

81.7%

ROE

MIRM

-28933.0%

PTCT

-35191.0%

FCF Yield %

PTCT

-0.7%

MIRM

-5.0%

52-Week Performance

MIRM

18.1%

PTCT

0.3%

Detailed metrics comparison

MIRM

Mirum Pharmaceuticals Inc

PTCT

PTC Therapeutics Inc

Market Cap

MIRM$5.24B

PTCT$5.37B

Enterprise Value

MIRM$5.66B

PTCT$7.24B

Price

MIRM$86.01

PTCT$64.70

P/E Ratio

MIRMN/A

PTCTN/A

P/S Ratio

MIRM8.49x

PTCT5.32x

EV/Sales

MIRM9.16x

PTCT7.17x

EV/EBITDA

MIRM2,753.41x

PTCT35.21x

P/B Ratio

MIRM22.21x

PTCT3,530.95x

P/FCF Ratio

MIRMN/A

PTCTN/A

EV/FCF

MIRM-21.48x

PTCT-182.20x

PEG Ratio

MIRMN/A

PTCTN/A

Forward P/E (NTM)

MIRMN/A

PTCT43.00x

Forward P/S (NTM)

MIRM6.85x

PTCT4.18x

Revenue (TTM)

MIRM$618M

PTCT$1.01B

Revenue Growth (YoY)

MIRM44.0%

PTCT-36.7%

Forward Rev Growth

MIRM17.0%

PTCT11.6%

Gross Margin (TTM)

MIRM81.7%

PTCT93.0%

Operating Margin (TTM)

MIRM0.0%

PTCT12.4%

EBITDA Margin (TTM)

MIRM-10.6%

PTCT17.1%

Net Margin (TTM)

MIRM-139.2%

PTCT-3.8%

FCF Margin (TTM)

MIRM-42.7%

PTCT-3.9%

Net Income (TTM)

MIRM$-860M

PTCT$-38M

FCF (TTM)

MIRM$-264M

PTCT$-40M

EPS (TTM)

MIRM-$13.57

PTCT-$0.42

ROE (TTM)

MIRM-28933.0%

PTCT-35191.0%

ROA (TTM)

MIRM-9655.0%

PTCT-132.0%

ROIC (TTM)

MIRM-13639.0%

PTCT-3977.0%

Cash

MIRM$331M

PTCT$1.05B

Debt

MIRM$750M

PTCT$2.92B

Net Cash/Debt

MIRM$-419M

PTCT$-1.87B

Current Ratio (TTM)

MIRM2.86x

PTCT3.39x

Quick Ratio (TTM)

MIRM2.62x

PTCT3.20x

Debt/Equity (TTM)

MIRM1.28x

PTCT848.93x

Debt/Assets (TTM)

MIRM0.0%

PTCT0.0%

Interest Coverage (TTM)

MIRMN/A

PTCTN/A

Net Debt/EBITDA (TTM)

MIRM0.00x

PTCT0.00x

Beta

MIRM0.75

PTCT0.50

52W Performance

MIRM18.1%

PTCT0.3%

YTD Performance

MIRM10.2%

PTCT-15.7%

% from 52W High

MIRM-33.8%

PTCT-28.8%

% from 52W Low

MIRM36.0%

PTCT5.7%

Asset Turnover (TTM)

MIRM0.69x

PTCT0.35x

FCF Yield (TTM)

MIRM-5.0%

PTCT-0.7%

Earnings Yield (TTM)

MIRM-16.4%

PTCT-0.7%

Dividend Yield (TTM)

MIRMN/A

PTCTN/A

Rule of 40

MIRM1.3

PTCT-40.7

EV/GP/RG

MIRM0.45

PTCT0.24

Ticker research

View MIRM research View PTCT research

Metric	MIRM Mirum Pharmaceuticals Inc	PTCT PTC Therapeutics Inc
Market & Valuation
Market Cap	$5.24B	$5.37B
Enterprise Value	$5.66B	$7.24B
Price	$86.01	$64.70
P/E Ratio	N/A	N/A
P/S Ratio	8.49x	5.32x
EV/Sales	9.16x	7.17x
EV/EBITDA	2,753.41x	35.21x
P/B Ratio	22.21x	3,530.95x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.48x	-182.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	43.00x
Forward P/S (NTM)	6.85x	4.18x
Revenue & Growth
Revenue (TTM)	$618M	$1.01B
Revenue Growth (YoY)	44.0%	-36.7%
Forward Rev Growth	17.0%	11.6%
Profitability
Gross Margin (TTM)	81.7%	93.0%
Operating Margin (TTM)	0.0%	12.4%
EBITDA Margin (TTM)	-10.6%	17.1%
Net Margin (TTM)	-139.2%	-3.8%
FCF Margin (TTM)	-42.7%	-3.9%
Net Income (TTM)	$-860M	$-38M
FCF (TTM)	$-264M	$-40M
EPS (TTM)	-$13.57	-$0.42
ROE (TTM)	-28933.0%	-35191.0%
ROA (TTM)	-9655.0%	-132.0%
ROIC (TTM)	-13639.0%	-3977.0%
Financial Health
Cash	$331M	$1.05B
Debt	$750M	$2.92B
Net Cash/Debt	$-419M	$-1.87B
Current Ratio (TTM)	2.86x	3.39x
Quick Ratio (TTM)	2.62x	3.20x
Debt/Equity (TTM)	1.28x	848.93x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	0.50
52W Performance	18.1%	0.3%
YTD Performance	10.2%	-15.7%
% from 52W High	-33.8%	-28.8%
% from 52W Low	36.0%	5.7%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.35x
FCF Yield (TTM)	-5.0%	-0.7%
Earnings Yield (TTM)	-16.4%	-0.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1.3	-40.7
EV/GP/RG	0.45	0.24
Ticker research	View MIRM research	View PTCT research